357 research outputs found
Two-photon mediated resonance production in e+e- collisions: cross sections and density matrices
Earlier described model amplitudes are used in this paper to evaluate both
cross sections and density matrices for two-photon mediated resonance
production in e^+e^- collisions. All 25 q\bar{q} low-lying ^1S_0, ^3P_J and
^1D_2 resonances can thus be treated. Two independent methods are described to
obtain the resonance production density matrices and cross sections. These
density matrices combined with a resonance decay density matrix give the
detailed angular distributions of the resonance decay products. For two
particular decays, \chi_{c2},\chi_{c1}\to\gamma J/\psi the details are given.
Several numerical results are presented as well.Comment: 27 pages, 4 figure
Radiative Decay of Vector Quarkonium: Constraints on Glueballs and Light Gluinos
Given a resonance of known mass, width, and J^{PC}, we can determine its
gluonic branching fraction, b(R->gg), from data on its production in radiative
vector quarkonium decay, V -> gamma+R. For most resonances b(R->gg) is found to
be O(10%), consistent with being q-qbar states, but we find that both
pseudoscalars observed in the 1440 MeV region have b(R->gg) ~ 1/2 - 1, and
b(f_0^{++}->gg) ~ 1/2. As data improves, b(R->gg) should be a useful
discriminator between q-qbar and gluonic states and may permit quantitative
determination of the extent to which a particular resonance is a mixture of
glueball and q-qbar. We also examine the regime of validity of pQCD for
predicting the rate of V -> gamma+eta_gluino, the ``extra'' pseudoscalar bound
state which would exist if there were light gluinos. From the CUSB limit on
peaks in Upsilon -> gamma X, the mass range 3 GeV < m(eta_gluino) < 7 GeV can
be excluded. An experiment must be significantly more sensitive to exclude an
eta_gluino lighter than this.Comment: 36pp (inc figs),RU-94-04. (Replaces original which didn't latex
correctly and didn't have figures.
Intra- and interspecies interactions between prion proteins and effects of mutations and polymorphisms
Recently, crystallization of the prion protein in a dimeric form was reported. Here we show that native soluble homogenous FLAG-tagged prion proteins from hamster, man and cattle expressed in the baculovirus system are predominantly dimeric. The PrP/PrP interaction was confirmed in Semliki Forest virus-RNA transfected BHK cells co-expressing FLAG- and oligohistidine-tagged human PrP. The yeast two-hybrid system identified the octarepeat region and the C-terminal structured domain (aa90-aa230) of PrP as PrP/PrP interaction domains. Additional octarepeats identified in patients suffering from fCJD reduced (wtPrP versus PrP+90R) and completely abolished (PrP+90R versus PrP+90R) the PrP/PrP interaction in the yeast two-hybrid system. In contrast, the Met/Val polymorphism (aa129), the GSS mutation Pro102Leu and the FFI mutation Asp178Asn did not affect PrP/PrP interactions. Proof of interactions between human or sheep and bovine PrP, and sheep and human PrP, as well as lack of interactions between human or bovine PrP and hamster PrP suggest that interspecies PrP interaction studies in the yeast two-hybrid system may serve as a rapid pre-assay to investigate species barriers in prion diseases
Meson Decay Constants from Isospin Mass Splittings in the Quark Model
Decay constants of and mesons are estimated within the framework of a
heavy-quark approach using measured isospin mass splittings in the , ,
and states to isolate the electromagnetic hyperfine interaction between
quarks. The values MeV and MeV are
obtained. Only experimental errors are given; possible theoretical ambiguities,
and suggestions for reducing them, are noted.Comment: 7 pages, LaTeX, EFI-92-3
Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
manuscript received October 15, 2003; revised manuscript received December 15, 2003; accepted December 16, 2003. We thanks P. Rondard, O Bischof, J.-L. Laplanche and J.-P. Pin for their fruitful discussions. we are grateful to S. barrère for her assistance in the statistical analysis of the data and H. McMahon for her assistance in reading the manuscript
Deep inelastic production at HERA in the -factorization approach and its consequences for the nonrelativistic QCD
In the framework of the -factorization approach, we analyse the
inclusive and inelastic production of particles in deep inelastic
scattering. We take into account both colour-singlet and colour-octet
production channels. We inspect the sensitivity of theoretical predictions to
the choice of model parameters. Our theoretical results agree reasonably well
with recent experimental data collected by the collaboration H1 at HERA.Comment: 14 pages, 6 figure
Wissenschaftliche Monitoringkonzepte für die Deutsche Bucht (WIMO) - Abschlussbericht
The state and development of coastal marine systems and an understanding of the interaction of
organisms, sea floor, water column, and biochemical and physical processes can only be obtained by
a combination of long-term monitoring and modelling approaches of different complexity. A need for the development and evaluation of monitoring strategies is driven by a framework of different
European and German regulations. The research project WIMO (Scientific Monitoring Concepts for the German Bight) has developed concepts and methods that aim at a fundamental scientific understanding of marine systems and also meet monitoring requirements of European legislation and regulations like the EU Marine Strategy Framework Directive. In this final report examples of common descriptors of ecosystem state like seabed integrity, eutrophication, and biodiversity are discussed. It has been assessed to what extent established measuring procedures used to survey the characteristics of the sea floor, and newly developed technologies are eligible for governmental monitoring. The significance of integrative modelling for linking and visualising results of measurements and
models is illustrated. It is shown how new concepts have been implemented into governmental monitoring in the form of web based data sheets. These insights enable continuous analyses and developments in the future
Leptonic and Semileptonic Decays of Charm and Bottom Hadrons
We review the experimental measurements and theoretical descriptions of
leptonic and semileptonic decays of particles containing a single heavy quark,
either charm or bottom. Measurements of bottom semileptonic decays are used to
determine the magnitudes of two fundamental parameters of the standard model,
the Cabibbo-Kobayashi-Maskawa matrix elements and . These
parameters are connected with the physics of quark flavor and mass, and they
have important implications for the breakdown of CP symmetry. To extract
precise values of and from measurements, however,
requires a good understanding of the decay dynamics. Measurements of both charm
and bottom decay distributions provide information on the interactions
governing these processes. The underlying weak transition in each case is
relatively simple, but the strong interactions that bind the quarks into
hadrons introduce complications. We also discuss new theoretical approaches,
especially heavy-quark effective theory and lattice QCD, which are providing
insights and predictions now being tested by experiment. An international
effort at many laboratories will rapidly advance knowledge of this physics
during the next decade.Comment: This review article will be published in Reviews of Modern Physics in
the fall, 1995. This file contains only the abstract and the table of
contents. The full 168-page document including 47 figures is available at
http://charm.physics.ucsb.edu/papers/slrevtex.p
The effects of percutaneous branch pulmonary artery interventions in biventricular congenital heart disease:study protocol for a randomized controlled Dutch multicenter interventional trial
Background: Branch pulmonary artery (PA) stenosis is one of the most common indications for percutaneous interventions in patients with transposition of the great arteries (TGA), tetralogy of Fallot (ToF), and truncus arteriosus (TA). However, the effects of percutaneous branch PA interventions on exercise capacity remains largely unknown. In addition, there is no consensus about the optimal timing of the intervention for asymptomatic patients according to international guidelines. This trial aims to identify the effects of percutaneous interventions for branch PA stenosis on exercise capacity in patients with TGA, ToF, and TA. In addition, it aims to assess the effects on RV function and to define early markers for RV adaptation and RV dysfunction to improve timing of these interventions. Methods: This is a randomized multicenter interventional trial. TGA, ToF, and TA patients ≥ 8 years with a class IIa indication for percutaneous branch PA intervention according to international guidelines are eligible to participate. Patients will be randomized into the intervention group or the control group (conservative management for 6 months). All patients will undergo transthoracic echocardiography, cardiac magnetic resonance (CMR) imaging, and cardiopulmonary exercise testing at baseline, 6 months, and 2–4 years follow-up. Quality of life (QoL) questionnaires will be obtained at baseline, 2 weeks post intervention or a similar range for the control group, and 6 months follow-up. The primary outcome is exercise capacity expressed as maximum oxygen uptake (peak VO2 as percentage of predicted). A total of 56 patients (intervention group n = 28, control group n = 28) is required to demonstrate a 14% increase in maximum oxygen uptake (peak VO2 as percentage of predicted) in the interventional group compared to the control group (power 80%, overall type 1 error controlled at 5%). Secondary outcomes include various parameters for RV systolic function, RV functionality, RV remodeling, procedural success, complications, lung perfusion, and QoL. Discussion: This trial will investigate the effects of percutaneous branch PA interventions on exercise capacity in patients with TGA, ToF, and TA and will identify early markers for RV adaptation and RV dysfunction to improve timing of the interventions. Trial registration: ClinicalTrials.gov NCT05809310. Registered on March 15, 2023.</p
- …
